Sector Watch: Healthcare - Sep 14 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $117.77 -0.60 -0.51% | XBI: $95.83 -0.07 -0.07% | Updated Sep 14, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| CSBR52WH Champions Oncology $116.8M |
10.58+2.10 1.8 M 35.1x |
25% | ||
| NVTA52WH Invitae $1.1B |
15.58+1.96 7.3 M 5.0x |
14% | ||
| CVM Cel-Sci $84.5M |
3.59+0.43 1.6 M |
14% | ||
| PRQR ProQR Therapeutics $783.8M |
20.80+2.35 1.0 M 1.6x |
13% | ||
| NWBO Northwest Biotherapeutics $93.8M |
0.21+0.02 1.8 M 2.1x |
12% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| OPK Opko Health Inc $2.2B |
3.90-0.68 26.7 M 6.7x |
-15% | ||
| IRIX IRIDEX $78.0M |
6.69-1.06 267.7 K 22.2x |
-14% | ||
| SRNE Sorrento Therapeutics $504.9M |
4.33-0.48 3.5 M 3.1x |
-10% | ||
| VVUS VIVUS $59.8M |
5.63-0.58 93.6 K |
-9% | ||
| OMI Owens & Minor $1.0B |
16.31-1.44 1.5 M |
-8% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ? OPK [globenewswire.com]CEL-SCI Receives $5.4 Million from Warrant Exercises | Business Wire [businesswire.com]
Nasdaq Scheduled Resumption in OPKO Health, Inc. [globenewswire.com]
Barrack, Rodos & Bacine Files Securities Class Action Lawsuit Against OPKO Health, Inc. [globenewswire.com]
CLASS ACTION UPDATE for OPK and FIZZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
IRIDEX Announces Pricing of Public Offering of Common Stock [globenewswire.com]
OPK LOSS NOTICE: Rosen Law Firm Reminds OPKO Health, Inc. Investors of Important Deadline in First Filed Case by Firm | Business Wire [businesswire.com]
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of OPKO Health, Inc. Investors | Business Wire [businesswire.com]
IRIDEX Announces Proposed Public Offering of Common Stock [globenewswire.com]
OPKO Class Action: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. - OPK [globenewswire.com]
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against OPKO Health, Inc. ? OPK | Business Wire [businesswire.com]
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. (OPK) and Encourages Investors to Contact the Firm [globenewswire.com]
OPK LOSS NOTICE: Rosen Law Firm Reminds OPKO Health, Inc. Investors of Important Deadline in First Filed Case by Firm | Business & Finance | manchestertimes.com [businesswire.com]
Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth [globenewswire.com]
Brain Hemorrhage: 2018 Pipeline Insight Report - Analysis by Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.com | Business Wire [businesswire.com]
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against OPKO Health, Inc. ? OPK | Business & Finance | manchestertimes.com [businesswire.com]
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Opko Health, Inc. Investors | Business Wire [businesswire.com]
INVESTIGATION ALERT REMINDER: The Schall Law Firm Announces it is Investigating Claims Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | Business Wire [businesswire.com]
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters? Option to Purchase Additional Shares [globenewswire.com]
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock | Business Wire [businesswire.com]
Invitae Appoints Chitra Nayak to its Board of Directors [prnewswire.com]
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | Business Wire [businesswire.com]
Bragar Eagel & Squire, P.C. is Investigating OPKO Health, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm [globenewswire.com]
Having Raised Over USD 2.6 Billion in the Last Few Years, the Antibody Discovery Services Market is Poised for Uninterrupted Growth, Predicts Roots Analysis [prnewswire.com]
RM LAW Announces Investigation of OPKO Health, Inc. [prnewswire.com]
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against OPKO Health, Inc. ? OPK | Business Wire [businesswire.com]
VIVUS Announces 1-for-10 Reverse Stock Split [globenewswire.com]
Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing to Support the Commercialization of Non-Opioid ZTlido? Pain Medication [globenewswire.com]
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against OPKO Health, Inc. ? OPK | Business & Finance | heraldchronicle.com [businesswire.com]
OPKO Comments on SEC Complaint | Business Wire [businesswire.com]
OPKO Comments on SEC Complaint [businesswire.com]
2018 Pipeline Insights for Hyperphosphatemia by Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.com | Business Wire [businesswire.com]
Nasdaq Halts OPKO Health, Inc. [globenewswire.com]
Hyperparathyroidism: 2018 Pipeline Insights by Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.com | Business Wire [businesswire.com]
Global CAR-T Cell Therapy Market Report 2018 - Market Size, Forecasts, Trials & Trends to 2024 - ResearchAndMarkets.com | Business Wire [businesswire.com]
ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares [globenewswire.com]
OPKO Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. - OPK [prnewswire.com]
Human Papillomavirus Associated Diseases - Pipeline Insights 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Scilex Presents ZTlido? Data on Superior Adhesion over Lidocaine Patch Formulation [prnewswire.com]
IRIDEX Announces FDA Clearance to Introduce Updated TruFocus LIO Premiere? Laser Accessory to the U.S. Market [globenewswire.com]
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares [globenewswire.com]
NIH Selects CEL-SCI?s LEAPS Rheumatoid Arthritis Vaccine for Commercialization Accelerator Program | Business Wire [businesswire.com]
ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial Nasdaq:PRQR [globenewswire.com]
Hagens Berman Alerts Investors in OPKO Health (OPK) to the Firm's Investigation of Possible Disclosure Violations Related to Alleged "Pump-and-Dump" Scheme [prnewswire.com]
Champions Oncology Reports Record Quarterly Revenue of $6.2 Million [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
